Equities analysts predict that Cavium, Inc. (NASDAQ:CAVM) will report $250.05 million in sales for the current fiscal quarter, Zacks reports. Seven analysts have provided estimates for Cavium’s earnings, with estimates ranging from $249.16 million to $250.64 million. Cavium reported sales of $168.12 million in the same quarter last year, which would suggest a positive year-over-year growth rate of 48.7%. The firm is expected to announce its next quarterly earnings results on Tuesday, November 7th.

According to Zacks, analysts expect that Cavium will report full-year sales of $250.05 million for the current fiscal year, with estimates ranging from $976.70 million to $984.08 million. For the next year, analysts anticipate that the company will post sales of $1.10 billion per share, with estimates ranging from $1.08 billion to $1.13 billion. Zacks’ sales averages are an average based on a survey of research analysts that that provide coverage for Cavium.

Cavium (NASDAQ:CAVM) last released its earnings results on Wednesday, August 2nd. The semiconductor provider reported $0.67 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.65 by $0.02. Cavium had a negative net margin of 22.82% and a positive return on equity of 5.87%. The business had revenue of $242.09 million for the quarter, compared to analysts’ expectations of $238.93 million. During the same period last year, the company earned $0.29 earnings per share. The company’s quarterly revenue was up 125.8% on a year-over-year basis.

Several analysts have issued reports on CAVM shares. Zacks Investment Research downgraded Cavium from a “hold” rating to a “strong sell” rating in a report on Monday. Canaccord Genuity reiterated a “hold” rating on shares of Cavium in a report on Friday. BidaskClub downgraded Cavium from a “hold” rating to a “sell” rating in a report on Monday, July 31st. Barclays PLC upgraded Cavium from an “equal weight” rating to an “overweight” rating in a report on Friday, July 21st. Finally, Jefferies Group LLC upgraded Cavium from a “hold” rating to a “buy” rating and upped their target price for the company from $73.00 to $79.00 in a report on Monday, July 10th. Two equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and thirteen have given a buy rating to the company. The stock has a consensus rating of “Buy” and an average price target of $74.53.

COPYRIGHT VIOLATION NOTICE: This piece of content was published by American Banking News and is the property of of American Banking News. If you are reading this piece of content on another site, it was illegally copied and republished in violation of U.S. & international copyright and trademark laws. The legal version of this piece of content can be accessed at https://www.americanbankingnews.com/2017/08/08/250-05-million-in-sales-expected-for-cavium-inc-nasdaqcavm-this-quarter.html.

In related news, VP Arthur D. Chadwick sold 40,000 shares of the business’s stock in a transaction that occurred on Tuesday, May 16th. The stock was sold at an average price of $75.14, for a total value of $3,005,600.00. Following the completion of the sale, the vice president now owns 75,383 shares of the company’s stock, valued at approximately $5,664,278.62. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, SVP Vincent P. Pangrazio sold 15,000 shares of the business’s stock in a transaction that occurred on Tuesday, May 16th. The shares were sold at an average price of $75.73, for a total value of $1,135,950.00. Following the completion of the sale, the senior vice president now directly owns 60,039 shares of the company’s stock, valued at approximately $4,546,753.47. The disclosure for this sale can be found here. Insiders own 4.65% of the company’s stock.

A number of large investors have recently made changes to their positions in the company. Prudential Financial Inc. boosted its stake in shares of Cavium by 3.0% in the first quarter. Prudential Financial Inc. now owns 6,917 shares of the semiconductor provider’s stock worth $496,000 after buying an additional 200 shares during the last quarter. Gilder Gagnon Howe & Co. LLC boosted its stake in shares of Cavium by 73.6% in the first quarter. Gilder Gagnon Howe & Co. LLC now owns 628,020 shares of the semiconductor provider’s stock worth $45,004,000 after buying an additional 266,300 shares during the last quarter. Karp Capital Management Corp bought a new stake in shares of Cavium during the first quarter worth about $594,000. TIAA CREF Investment Management LLC boosted its stake in shares of Cavium by 65.4% in the first quarter. TIAA CREF Investment Management LLC now owns 321,352 shares of the semiconductor provider’s stock worth $23,028,000 after buying an additional 127,041 shares during the last quarter. Finally, Vanguard Group Inc. boosted its stake in shares of Cavium by 4.3% in the first quarter. Vanguard Group Inc. now owns 5,121,457 shares of the semiconductor provider’s stock worth $367,004,000 after buying an additional 211,144 shares during the last quarter.

Shares of Cavium (CAVM) opened at 61.11 on Tuesday. Cavium has a 52-week low of $46.78 and a 52-week high of $76.26. The firm’s market capitalization is $4.17 billion. The company has a 50 day moving average of $64.96 and a 200 day moving average of $68.19.

About Cavium

Cavium, Inc is a provider of integrated semiconductor processors that enable intelligent processing for wired and wireless infrastructure and cloud for networking, communications, storage and security applications. The Company’s products consist of multi-core processors for embedded and data center applications, network connectivity for server and switches, storage connectivity, and security processors for offload and appliance.

Get a free copy of the Zacks research report on Cavium (CAVM)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Cavium Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cavium Inc. and related companies with MarketBeat.com's FREE daily email newsletter.